Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003143912 | SCV003828790 | uncertain significance | Developmental and epileptic encephalopathy, 69 | 2022-01-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003561187 | SCV004304724 | uncertain significance | not provided | 2023-07-13 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 2439661). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CACNA1E protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with CACNA1E-related conditions. This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 77 of the CACNA1E protein (p.Ile77Met). This variant is not present in population databases (gnomAD no frequency). |